Recommended Articles

Uterine transplantation: the status quo in 2024

Natural Cycle vs. Induced Ovulation

Comparison of sustained blastocyst implantation rate at all ages

The effectiveness of ovulation induction is related to

Use of Preimplantation Genetic Testing for Aneuploidy (PGT-A)

The use of preimplantation genetic testing for aneuploidy (PGT-A) has been steadily increasing. The underlying technology for 24-chromosome analysis continues to evolve rapidly. 
 
The value of PGT-A as a routine screening test for all patients undergoing IVF has not been proven.
 
Although some early single-center studies reported higher rates of live births after PGT-A in patients with good prognosis
 
However, a recent multicenter randomized controlled trial of women with usable blastocysts concluded that
 
Overall pregnancy outcomes through frozen embryo transfer are similar between PGT-A.
 
The value of PGT-A in reducing the risk of clinical miscarriage is unknown. 
 
Conclusion: The American Journal of Fertility still does not recommend the routine use of PGT for all IVF patients.
 
 
 
The use of preimplantation genetic testing for aneuploidy: a committee opinion
The use of preimplantation genetic testing for aneuploidy (PGT-A) in the United States has been increasing steadily. Moreover, the underlying technology used for 24-chromosome analysis continues to evolve rapidly. The use of preimplantation genetic testing for aneuploidy (PGT-A) in the United States has been increasing steadily. Moreover, the underlying technology used for 24-chromosome analysis continues to evolve rapidly. The value of PGT-A as a routine screening test for all patients undergoing in vitro fertilization has not been demonstrated. Although some earlier single-center studies reported higher live-birth rates after PGT-A in favorable-prognosis patients, recent multicenter, randomized control trials in women with available blastocysts concluded that the overall pregnancy outcomes via frozen embryo transfer were similar. The value of PGT-A to lower the risk of clinical miscarriage is also unclear, although there are some studies reporting higher live-birth rates after PGT-A in favorable-prognosis patients. The value of PGT-A to lower the risk of clinical miscarriage is also unclear, although these studies have important limitations. This document replaces the document of the same name, last published in 2018.